Luxempart Valuation Multiples

Discover Luxempart's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like AFP ProVida, IntegraFin, Eurocommercial Properties, Australian United Investment Company and more.

Luxempart Overview

About Luxempart

Luxempart SA is an investment company that invests in a portfolio of listed and non-listed companies. The firm makes investments that vary from long-term to medium-term, with the majority of investments being in the long term. The company has two business segments; Direct Investments consist of taking direct participation in companies in the target geographical regions, which consist of the Benelux region (Belgium, Luxembourg), France, DACH region (Germany, Austria, Switzerland), and Italy, and The Investment Funds consists in the acquisition of shares in Investment Funds mainly active in private equity and venture capital.


Founded

1988

HQ

Luxembourg

Employees

28

Financials (FY)

Revenue: $327M
Net Income: $305M

EV

$1.7B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Luxempart Financials

Luxempart reported last fiscal year revenue of $327M.

In the same fiscal year, Luxempart generated $305M in net income.


Luxempart P&L

In the most recent fiscal year, Luxempart reported revenue of $327M and net income of $305M.

Luxempart is profitable as of last fiscal year, with net margin of 93%.

See analyst estimates for Luxempart
Last FY202320242025202620272028
Revenue$327M$238M$56M$327M
Net Profit$305M$212M$35M$305M
Net Margin93%89%63%93%

Financial data powered by Morningstar, Inc.

Luxempart Stock Performance

Luxempart has current market cap of $1.8B, and enterprise value of $1.7B.

Market Cap Evolution


Luxempart's stock price is $87.06.

Luxempart share price decreased by 0.1% in the last 30 days, and increased by 9.7% in the last year.

Luxempart has an EPS (earnings per share) of $15.13.

See more trading valuation data for Luxempart
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1.7B$1.8B-0.1%-0.1%4.5%9.7%$15.13

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Luxempart Valuation Multiples

Luxempart trades at 5.1x EV/Revenue multiple.

See NTM and 2027E valuation multiples for Luxempart

Luxempart Financial Valuation Multiples

As of August 25, 2026, Luxempart has market cap of $1.8B and EV of $1.7B.

Luxempart has a P/E ratio of 5.8x.

Last FY202320242025202620272028
EV/Revenue5.1x7.1x29.8x5.1x
P/E5.8x8.3x49.8x5.8x
EV/FCF33.1x(11.1x)17.7x33.1x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Luxempart Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Luxempart Margins & Growth Rates

In the most recent fiscal year, Luxempart reported net margin of 93%.

See estimated margins and future growth rates for Luxempart

Luxempart Margins

Last FY20242025202720282029
Net Margin93%63%93%
FCF Margin16%169%16%

Luxempart Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(76%)480%
Net Profit Growth(83%)765%
FCF Growth(162%)(46%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Luxempart Operational KPIs

Luxempart's revenue per employee in the last FY averaged $11.7M, while opex per employee averaged $0.3M for the same period.

Access forward-looking KPIs for Luxempart
Last FY202320242025202620272028
Revenue per Employee$11.7M---
Opex per Employee$0.3M---
G&A Expenses to Revenue1%1%6%1%
Opex to Revenue3%10%36%3%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Luxempart Competitors

Luxempart competitors include AFP ProVida, IntegraFin, Eurocommercial Properties, Australian United Investment Company, FII Ancar IC, Tamburi Inv Partners, Montea, Icade, Metrics Master Income and Deterra Royalties.

Most Luxempart public comparables operate across Asset Management.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
AFP ProVida4.7x-7.3x-
IntegraFin7.3x6.6x11.7x14.3x
Eurocommercial Properties10.9x13.0x11.4x16.0x
Australian United Investment Company48.6x---
FII Ancar IC----
Tamburi Inv Partners164.1x721.9x28.2x(96.2x)
Montea9.3x10.3x7.9x10.6x
Icade3.5x14.8x(96.4x)16.1x

This data is available for Pro users. Sign up to see all Luxempart competitors and their valuation data.

Start Free Trial

Acquisitions by Luxempart

Luxempart has acquired 12 companies to date.

Last acquisition by Luxempart was on December 16th 2025. Luxempart acquired VALEARA for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Luxempart

VALEARA
Assmann
Nexus AG
Rimed
Description
VALEARA is a Germany-based provider of specialized care for psychiatric, neurological conditions, and physiotherapy services.
Assmann is a German supplier of server, network and peripheral infrastructure products. The group sources components directly in Asia and distributes across Europe, mainly through resellers and distributors rather than end customers. Assmann covers connectivity, cabinets, power and workplace peripherals for IT installers and integrators.
Nexus AG is a Germany-headquartered healthcare IT provider operating in 23 European countries and the Middle East. The company develops software for hospitals, rehabilitation centers, and senior care facilities focused on medical documentation and information management. Nexus AG delivers modular applications that integrate patient data across departments for streamlined clinical processes.
Rimed is a Swiss diagnostic radiology group running a network of imaging centres across the German- and Italian-speaking cantons. The business covers general radiology as well as interventional procedures, serving referring physicians and hospitals on an outpatient basis. Rimed bills payers and patients for imaging examinations performed at its sites.
HQ CountryGermanyGermanyGermanySwitzerland
HQ City
-
Ludenscheid
Donaueschingen
Zug
Deal Date16 Dec 20255 Dec 20255 Nov 20243 Nov 2022
Valuationundisclosedundisclosed$1.3Bundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Luxempart acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Luxempart

Luxempart has invested in 11 companies to date.

Latest investment by Luxempart was on June 20th 2024. Luxempart invested in Medios in their Secondary round.

See VC round multiples

Latest Investments by Luxempart

Medios
alphacaps
Coutot-Roehrig
Kestrel Vision
Description
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
alphacaps is a German contract developer and manufacturer of nutritional supplements. The company formulates and produces supplements on behalf of brand owners across a wide span of dosage formats, backed by the certifications required for food supplement production. Revenue comes from manufacturing contracts rather than own-brand sales.
Coutot-Roehrig is a probate research firm that traces and identifies heirs in estates left without known beneficiaries. Notaries and other legal officers appoint the company to establish entitlement and see estates through to settlement. The business works from a proprietary archive of digitised records covering more than a billion data points, backed by 46 branch offices in France, Spain, Italy, Belgium, Luxembourg, Switzerland, Monaco and the United States, plus a correspondent network reaching further afield. Coutot-Roehrig has traded since 1894 and reported revenues above EUR 70 million in 2022.
Kestrel Vision is a machine vision group serving the container inspection market. The company designs its own inspection systems and outsources their manufacture, running a fabless model, and sells them with data collection, analytics and support services attached. Its equipment checks the production and filling of rigid containers, mainly for food and beverage customers and to a smaller degree for pharmaceutical producers. Kestrel Vision started in glass packaging and has moved into plastic and metal packaging through acquisitions, with around two thirds of sales made outside Europe.
HQ CountryGermanyGermanyFranceFrance
HQ City
Berlin
Augustdorf
Paris
Saint-Genis-Laval
Deal Date20 Jun 202430 Oct 202319 Apr 20236 Feb 2023
RoundSecondaryUndisclosed stageUndisclosed stageUndisclosed stage
Raisedundisclosedundisclosedundisclosedundisclosed
InvestorsLuxempartLuxempartLuxempartLuxempart; Caravelle SA
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Luxempart investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Luxempart

When was Luxempart founded?Luxempart was founded in 1988.
Where is Luxempart headquartered?Luxempart is headquartered in Luxembourg.
How many employees does Luxempart have?As of today, Luxempart has over 28 employees.
Is Luxempart publicly listed?Yes, Luxempart is a public company listed on Luxembourg Stock Exchange.
What is the stock symbol of Luxempart?Luxempart trades under LXMPR ticker.
When did Luxempart go public?Luxempart went public in 1988.
Who are competitors of Luxempart?Luxempart main competitors include AFP ProVida, IntegraFin, Eurocommercial Properties, Australian United Investment Company, FII Ancar IC, Tamburi Inv Partners, Montea, Icade, Metrics Master Income, Deterra Royalties.
What is the current market cap of Luxempart?Luxempart's current market cap is $1.8B.
What is the current revenue of Luxempart?Luxempart's last fiscal year revenue is $327M.
What is the current EV/Revenue multiple of Luxempart?Current revenue multiple of Luxempart is 5.1x.
Is Luxempart profitable?No, Luxempart is not profitable.
How many companies Luxempart has acquired to date?As of August 2026, Luxempart has acquired 10 companies.
What was the largest acquisition by Luxempart?$4B acquisition of Zooplus on 13th August 2021 was the largest M&A Luxempart has done to date.
What companies Luxempart acquired?Luxempart acquired Zooplus, Nexus AG, Schaltbau Holding, VALEARA, Novotergum, Tonies, Assmann, Rattay, Baobab Collection, and Rimed.
In how many companies Luxempart has invested to date?As of August 2026, Luxempart has invested in 11 companies.
What was the last Luxempart investment?On 20th June 2024 Luxempart invested in Medios, participating in a Secondary round.

See public comps similar to Luxempart

Lists including Luxempart

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial